Pharmacology Books

Book SynopsisA key requirement of the primary and final FRCA examinations is a sound understanding of the basic sciences behind anaesthetic practice. It is important to be able to describe these principles clearly, particularly in the viva section of the examinations. Featuring several new topics, this fully updated new edition of this best-selling book provides all the important graphs, definitions and equations which may be covered in the examinations, together with clear and concise explanations of how to present them to the examiner and why they are important. Packed full of precise, clear diagrams with well structured explanations, and with all key definitions, derivations and statistics, this is an essential study aid for all FRCA examination candidates.Table of ContentsAcknowledgements; Preface; Forewords P. Hutton and Tom E. Peck; Introduction; 1. Mathematical principles; 2. Physical principles; 3. Principles of special equipment; 4. Pharmacological principles; 5. Pharmacodynamics; 6. Pharmacokinetics; 7. Respiratory physiology; 8. Cardiovascular physiology; 9. Renal physiology; 10. Neurophysiology; 11. Applied sciences; 12. Statistical principles; Appendix; Index.

Read more less

Book SynopsisTrade ReviewThe Risks of Prescription Drugs explains in clear, concise, and unflinching language the consequences of ignoring the discrepancy between the drug industry's private interests and the public service we hope and naively expect from them. This book provides consumers with tools for self-defense and concerned citizens with a road map for rebalancing American medicine. -- John Abramson, Harvard Medical School, author of Overdosed America: The Broken Promise of American Medicine This volume introduces important debates on pharmaceutical promotion and marketing, needed drug evaluation and regulation, professional conflicts of interest, and increased medicalization of behavior. It explores important trends and policy questions that all engaged citizens should consider. -- David Mechanic, Rutgers Institute for Health, Health Care Policy, and Aging Research, and author of The Truth About Health Care: Why Reform Is Not Working in America This is a sensible, readable and constructive book that could in various respects open the reader's eyes, and then lead him, with his eyes wide open, along the road to a healthier world. -- M.N.G. Dukes International Journal of Risk and Safety in Medicine This well-referenced title will be of particular interest to prescribers, but I recommend it to all healthcare professionals. -- Roger Evans Nursing StandardTable of Contents1. Bearing the Risks of Prescription Drugs, by Donald W. Light 2. The Food and Drug Administration: Inadequate Protection from Serious Risks, by Donald W. Light 3. The Commercialization of Medical Decisions: Physicians and Patients at Risk, by Howard Brody 4. Pharmaceuticals and the Medicalization of Social Life, by Allan V. Horwitz 5. Medicalization and Risk Scares: The Case of Menopause and HRT, by Cheryl Stults and Peter Conrad Epilogue. Toward Safer Prescribing and Better Drugs, by Donald W. Light List of Contributors

Read more less

Book Synopsis

Read more less

Book SynopsisMedicinal Natural Products: A Biosynthetic Approach, Third Edition, provides a comprehensive and balanced introduction to natural products from a biosynthetic perspective, focussing on the metabolic sequences leading to various classes of natural products.Trade Review"Students should be empowered for a deductive analysis of the presented substances." (Arzneimittelforschung, December 2009) "This new edition is an excellent text that is unrivaled in both its scope and overall coverage of natural products biosynthesis." (Journal of Medicinal Chemistry, August 2009) "There is no question that this is the best book available on the biosynthesis and bio-organic chemistry of medicinally important natural products." (Education in Chemistry, September 2009)Table of Contents1 About this book, and how to use it 1 The subject 1 The aim 1 The approach 2 The topics 2 The figures 2 Further reading 3 What to study 3 What to learn 3 Nomenclature 3 Conventions regarding acids, bases, and ions 4 Some common abbreviations 4 Further reading 5 2 Secondary metabolism: the building blocks and construction mechanisms 7 Primary and secondary metabolism 7 The building blocks 8 The construction mechanisms 11 Alkylation reactions: nucleophilic substitution 12 Alkylation reactions: electrophilic addition 12 Wagner–Meerwein rearrangements 15 Aldol and Claisen reactions 15 Imine formation and the Mannich reaction 18 Amino acids and transamination 20 Decarboxylation reactions 22 Oxidation and reduction reactions 24 Dehydrogenases 24 Oxidases 26 Monooxygenases 26 Dioxygenases 26 Amine oxidases 27 Baeyer–Villiger monooxygenases 27 Phenolic oxidative coupling 28 Halogenation reactions 28 Glycosylation reactions 31 Elucidating biosynthetic pathways 34 Further reading 38 3 The acetate pathway: fatty acids and polyketides 39 Fatty acid synthase: saturated fatty acids 39 Unsaturated fatty acids 44 Uncommon fatty acids 53 Prostaglandins 58 Thromboxanes 64 Leukotrienes 64 Polyketide synthases: generalities 66 Polyketide synthases: macrolides 68 Polyketide synthases: linear polyketides and polyethers 90 Diels–Alder cyclizations 96 Polyketide synthases: aromatics 96 Cyclizations 99 Post-polyketide synthase modifications 103 Starter groups 116 Further reading 131 4 The shikimate pathway: aromatic amino acids and phenylpropanoids 137 Aromatic amino acids and simple benzoic acids 137 Phenylpropanoids 148 Cinnamic acids and esters 148 Lignans and lignin 152 Phenylpropenes 156 Benzoic acids from C6C3 compounds 157 Coumarins 161 Aromatic polyketides 166 Styrylpyrones, diarylheptanoids 166 Flavonoids and stilbenes 167 Flavonolignans 173 Isoflavonoids 174 Terpenoid quinones 178 Further reading 184 5 The mevalonate and methylerythritol phosphate pathways: terpenoids and steroids 187 Mevalonic acid and methylerythritol phosphate 188 Hemiterpenes (C5) 192 Monoterpenes (C10) 193 Irregular monoterpenes 204 Iridoids (C10) 206 Sesquiterpenes (C15) 210 Diterpenes (C20) 223 Sesterterpenes (C25) 234 Triterpenes (C30) 234 Triterpenoid saponins 242 Steroids 247 Stereochemistry and nomenclature 247 Cholesterol 248 Phytosterols 251 Vitamin D 256 Steroidal saponins 259 Cardioactive glycosides 265 Bile acids 275 Adrenocortical hormones/corticosteroids 277 Semi-synthesis of corticosteroids 277 Progestogens 287 Oestrogens 290 Androgens 296 Tetraterpenes (C40) 298 Higher terpenoids 306 Further reading 306 6 Alkaloids 311 Alkaloids derived from ornithine 311 Polyamines 311 Pyrrolidine and tropane alkaloids 312 Pyrrolizidine alkaloids 324 Alkaloids derived from lysine 326 Piperidine alkaloids 326 Quinolizidine alkaloids 328 Indolizidine alkaloids 330 Alkaloids derived from nicotinic acid 331 Pyridine alkaloids 331 Alkaloids derived from tyrosine 336 Phenylethylamines and simple tetrahydroisoquinoline alkaloids 336 Modified benzyltetrahydroisoquinoline alkaloids 346 Phenethylisoquinoline alkaloids 359 Terpenoid tetrahydroisoquinoline alkaloids 363 Amaryllidaceae alkaloids 365 Alkaloids derived from tryptophan 366 Simple indole alkaloids 366 Simple β-carboline alkaloids 369 Terpenoid indole alkaloids 369 Quinoline alkaloids 380 Pyrroloindole alkaloids 385 Ergot alkaloids 387 Alkaloids derived from anthranilic acid 395 Quinazoline alkaloids 395 Quinoline and acridine alkaloids 396 Alkaloids derived from histidine 398 Imidazole alkaloids 398 Alkaloids derived by amination reactions 400 Acetate-derived alkaloids 401 Phenylalanine-derived alkaloids 401 Terpenoid alkaloids 406 Steroidal alkaloids 406 Purine alkaloids 413 Caffeine 413 Saxitoxin and tetrodotoxin 416 Further reading 417 7 Peptides, proteins, and other amino acid derivatives 421 Peptides and proteins 421 Ribosomal peptide biosynthesis 422 Peptide hormones 426 Thyroid hormones 426 Hypothalamic hormones 427 Anterior pituitary hormones 429 Posterior pituitary hormones 430 Pancreatic hormones 432 Interferons 433 Opioid peptides 434 Ribosomal peptide toxins 434 Enzymes 438 Non-ribosomal peptide biosynthesis 438 Modified peptides: penicillins, cephalosporins, and other β-lactams 458 Penicillins 458 Cephalosporins 465 Other β-lactams 469 Cyanogenic glycosides 476 Glucosinolates 477 Cysteine sulfoxides 480 Further reading 481 8 Carbohydrates 485 Monosaccharides 485 Oligosaccharides 490 Polysaccharides 493 Aminosugars and aminoglycosides 498 Further reading 507 Index 509

Read more less

Book SynopsisThe Merck Index is the definitive reference work for scientists and professionals looking for authoritative information on chemicals, drugs and biologicals. It has been the leading source of information on chemical compounds for generations of scientists and professionals, selling over one million copies since its publication in 1889. The Merck Index contains over 10,000 monographs with information relating to compounds of significance in research, commerce and environmental impact. The 15th edition, available from Royal Society of Chemistry publishing for the first time, is fully revised and updated and contains over 500 new monographs. Over 35% of the existing entries have been updated since the last edition, molecular weights have been recalculated with the latest IUPAC standards and there are revised periodic table and atomic weight tables. The Merck Index is an essential reference for all scholarly and professional chemists, biochemists, pharmacists and toxicologists and of interest to students, teachers, academic libraries, academic researchers, information professionals, solicitors, journalists and government agencies. *The name THE MERCK INDEX is owned by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A., and is licensed to The Royal Society of Chemistry for use in the U.S.A. and Canada.

Read more less

Book SynopsisThe US Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? This book traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints.Trade ReviewWinner of the 2011 Allan Sharlin Memorial Award, Social Science History Association "Reputation and Power is ... and authoritative and well researched book. Political scientists will admire Carpenter's scholarship. It is, indeed, a good mix of history, politics, gossip, and intrigue."--Michael Rawlins, Lancet "In his massive, magisterial Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA, the Harvard political scientist Daniel Carpenter provides both a history of the agency and an analysis of how it gained and flexed its most important regulatory power, the ability to keep new drugs off the market. Carpenter carefully documents the ways FDA bureaucrats have worked to exploit opportunities to expand their influence and reshape how the drug industry and the medical profession operate."--Keith E. Wittington, Reason "This immense volume considers the Food and Drug Administration's regulation of the pharmaceutical industry, focusing on the connection between the FDA's stellar reputation and its ability to wield power as a regulatory body. The book is exceptional, successfully combining an array of methodological approaches."--Choice "Carpenter's book has much to offer. Reputation and Power will be a valuable resource for anyone who is interested in understanding US pharmaceutical regulation and the debates surrounding it."--Mary K. Olson, Health Affairs "This book succeeds quite well in achieving its ambitious objectives. It provides a compelling and useful account for the exceptional role of the FDA in American society, government, and regulation. Perhaps more importantly for organizational scholars, it provides a very rich case study of the evolution of an organization's reputation, image and power and how these combine to affect its performance."--Thomas D'Aunno, Administrative Science Quarterly "Carpenter's book was ten years in the making and it shows. The research is wide ranging and groundbreaking and the impressive range of materials will certainly help expand the field... Reputation and Power is essential reading for modern historians of medicine. In a renewed climate of interest in regulation, it is a sober addition to the previous polemical debates about the world of pharmaceuticals and their regulation and is sure to generate a broad discussion."--Lucas Richert, Social History of Medicine "Reputation and Power ... is a masterful study in the best tradition of political science and will stand as a definitive treatment of regulation, and not merely of the FDA's policies and practices. Along with his earlier work, this book will be an essential part of the emerging study of the American administrative state, whether that study takes place in political science, history, sociology, law, or, indeed, in schools of medicine and pharmacology."--John Ferejohn, Perspectives on PoliticsTable of ContentsLIST OF ILLUSTRATIONS ix LIST OF TABLES xi ACKNOWLEDGMENTS xiii LIST OF ABBREVIATIONS AND ACRONYMS xvii INTRODUCTION: The Gatekeeper 1 CHAPTER ONE: Reputation and Regulatory Power 33 PART ONE: ORGANIZATIONAL EMPOWERMENT AND CHALLENGE CHAPTER TWO: Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath 73 CHAPTER THREE: The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961 118 CHAPTER FOUR: Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966 228 CHAPTER FIVE: Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986 298 CHAPTER SIX: Reputation and Power Contested: Emboldened Audiences in Cancer and AIDS, 1977-1992 393 PART TWO: PHARMACEUTICAL REGULATION AND ITS AUDIENCES CHAPTER SEVEN: Reputation and the Organizational Politics of New Drug Review 465 CHAPTER EIGHT: The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite 544 CHAPTER NINE: The Other Side of the Gate: Reputation, Power, and Post-Market Regulation 585 CHAPTER TEN: The Detente of Firm and Regulator 635 CHAPTER ELEVEN: American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies 686 CHAPTER TWELVE: Conclusion: A Reputation in Relief 727 PRIMARY SOURCES AND ARCHIVAL COLLECTIONS 753 INDEX 759

Read more less

Book SynopsisThis second edition of Clarke's Analytical Forensic Toxicology offers a fresh perspective on the drugs and poisons that you are most likely to encounter in forensic toxicology, with a focus on collection, extraction and analysis.Trade Review"...a useful reference for students both undergraduate and postgraduate, as well as toxicologists who are relatively new to this discipline...There are many chapters from experienced toxicologists (many who are familiar to us) and the book is well structured and follows a consistent approach to understanding the essentials of forensic toxicology...There is a comprehensive number of chapters on techniques (extraction and analysis) and the major chromatographic approaches are covered well by recognised authors with considerable expertise...So if you have the 4th edition of Clarke's Analysis of Drugs and Poisons would you also buy this volume as well? Yes I would because the book is geared to a more novice readership - students, researchers and inexperienced toxicologists." Dimitri Gerostamoulos, TIAFT Bulletin 43(2), July 2013. -- Dimitri Gerostamoulos * TIAFT Bulletin *"This new edition is based on content in volume 1 of Clarke's Analysis of Drugs and Poisons, and modified for student use...this volume is full of useful information that will allow students to become familiar with the field. Summing up: Recommended. Upper-division undergraduates and graduate students." J. Allison, The College of New Jersey, CHOICE (51:3) November 2013. -- J. Allison * CHOICE *Table of Contents1. Introduction to Forensic Toxicology 2. Pharmacokinetics and Metabolism 3. Drugs of Abuse 4. Other Poisons 5. Workplace Drug Testing 6. Alternative Specimens 7. Postmortem Toxicology 8. Clinical Toxicology 9. Drug Abuse in Sport 10. Drug-Facilitated Sexual Assault 11. Alcohol, Drugs and Driving 12. Forensic Chemistry & Solid Dosage Form Identification 13. Sampling, Storage and Stability 14. Extraction 15. Colour Tests and Thin-Layer Chromatography 16. Immunoassays 17. Ultraviolet, Visible and Fluorescence Spectrophotometry 18. Infrared Spectroscopy 19. Gas Chromatography 20. High-Performance Liquid Chromatography 21. Mass Spectrometry 22. Quality Control and Assessment

Read more less

Book SynopsisGet your baby off to a great start with gentle and safe homemade lotions, powders, creams, and shampoos. In this informative guide to natural baby care, Colleen Dodt offers easy-to-follow aromatic recipes that make creative use of herbs and essential oils while avoiding harsh chemicals. With simple homeopathic remedies for a variety of ailments, Dodt provides plenty of suggestions for ensuring glowing health and creating a relaxing atmosphere that can enhance the magical bond between you and your baby.

Read more less

Book SynopsisDiscover the fragrant world of essential oils. Herbalist Colleen K. Dodt profiles the healing and cleaning powers of dozens of oils extracted from herbs, flowers, roots, barks, and resins. This comprehensive guide includes recipes for natural cleaning products, lotions, and ointments that will keep you feeling happy and smelling great. Fill your days with stimulating scents as you learn to use essential oils to wash your dishes, soothe sunburns, combat stress, and improve the quality of your life.

Read more less

Book SynopsisEin praktisches Taschenbuch zum schnellen Nachschlagen für Pflegefachkräfte in stationären und ambulanten Pflegeeinrichtungen. Für einen verantwortungsvollen und bewussten Umgang mit Psychopharmaka in der Betreuung älterer Menschen.Hier finden Pflegende die wichtigsten Fakten zur Psychopharmakotherapie: - Wirkung und Nebenwirkungen verschiedener Medikamentengruppen- Wechselwirkungen mit anderen Medikamenten- Medikamentenprofile nach Handelsnamen und Wirkstoffen in alphabetischer Reihenfolge Dieses Wissen befähigt Pflegekräfte in der Kommunikation mit dem Arzt: über negative Wechselwirkungen und Folgeerscheinungen, z.B. z.B. Desorientierung, erhöhte Sturzgefahr, Immobilität, einer eingestellten Medikation zu informieren. Auch informiert die erfahrene Autorin über alternative Angebote z.B. der Basalen Stimulation, Seelsorge, Physiotherapie, Ergotherapie, Aromatherapie.Table of ContentsUmgang mit Medikamenten.- Antidementiva.- Antidepressiva.- Schlaf- und Beruhigungsmittel.- Antipsychotika.- Besondere Probleme älterer Menschen.- Alternativen.- Anhang.- Literatur.

Read more less

Book SynopsisAn accessible book for clinicians at all levels of training and experience who prescribe psychiatric medications and wish to better understand the rationale and empirical evidence base behind choosing treatments optimally tailored to the needs of individual patients.Trade Review'Psychopharmacology textbooks are typically either scholarly, endlessly long and inaccessible to clinicians, or clinician-friendly but with inadequate documentation for readers who want more detailed information. Somehow, Goldberg and Stahl's Practical Psychopharmacology combines the best of these two styles. It is astonishingly comprehensive with many Tables citing every relevant study while simultaneously providing the deep practical wisdom and experience of the two authors, both of whom are world class clinician-scholars. Practical Psychopharmacology also provides a sophisticated yet accessible review of the biological underpinnings of both psychopathology and medication effects. It does not just inform; it teaches the reader how to think about medications. This book will set the standard in our field for the foreseeable future.' Michael Gitlin, Distinguished Professor of Clinical Psychiatry, Director, Adult Division of Psychiatry, Director, Mood Disorders Clinic, Geffen School of Medicine at UCLA'The translation of clinical research findings into practice is fraught. The methodology of many trials is imperfect, complex, and opaque and hard to generalise to real world patients. Many critical questions are poorly answered by the extant evidence. The basic neuroscience is extraordinarily complex. This book is a Rosetta stone for translating this evidence into practice in providing a critical bridge for practising clinicians in distilling and interpreting the evidence into clear and coherent pragmatic management and prescribing recommendations. Written by two of the world's premier authorities, it is infused with a rare synergy of clinical wisdom and neuroscience expertise and is an essential resource for any practising prescriber of psychotropic agents.' Michael Berk, NHMRC Senior Principal Research Fellow; Alfred Deakin Professor of Psychiatry, School of Medicine, Deakin University and Barwon Health; Director, IMPACT, the Institute for Mental and Physical Health and Clinical Translation'Drs. Goldberg and Stahl have reminded us that they are scientific artisans by creating a pragmatic, patient-centered set of guiding principles in clinical psychopharmacology. The emergence of newer psychopharmacologic treatments and expansion of indications for previously available agents has provided hope for identifying therapeutic avenues for patients to improve their general wellbeing, but also can feel daunting, overwhelming, and a source of entropy. Consequently, it is not uncommon for clinicians at point of care to be genuinely perplexed as to which treatments and capabilities are 'promising rather than prime-time'. The authors have deftly synthesized the scientific literature and have produced a book that is comprehensive, concise, and an invaluable source of decision support at the point of care for multidisciplinary practitioners who provide care to persons with mental disorders.' Roger S. McIntyre, Professor of Psychiatry and Pharmacology and Head, Mood Disorders Psychopharmacology Unit, University of Toronto, CanadaTable of ContentsPart I. General Principles: 1. Core concepts of good psychopharmacology; 2. Targets of treatment: categories versus dimensions of psychopathology; 3. Interpreting and using the literature: integrating evidence-based trials with real-world practice; 4. Placebo and nocebo effects; 5. Tailoring the fit: moderators and mediators of treatment outcome; 6. Complex regimens and rationale-based combination drug therapies; 7. Laboratory values and psychiatric symptoms: what to measure, what not to measure, and what to do with the results; 8. Pharmacogenetics: when relevant, when not; 9. Cross-tapering and the logistics of drug discontinuation; 10. Managing major adverse drug effects: when to avoid, switch, or treat through; 11. Novel drug therapeutics: nutraceuticals, steroids, probiotics, and other dietary supplements; 12. Human diversity and considerations in special populations; Part II. Targets of Pharmacotherapy: 13. Disordered mood and affect; 14. Disorders of impulsivity, compulsivity, and aggression; 15. Psychosis; 16. Deficit states and negative symptoms; 17. Anxiety; 18. Addiction and the reward pathway; 19. Trauma and posttraumatic stress disorder; 20. Personality disorders; 21. Cognition; 22. Putting it all together; References; Index.

Read more less

Book SynopsisTable of ContentsUsing calculations in pharmacy practice Dispensing techniques (compounding and good practice) Oral unit dosage forms Packaging Solutions Suspensions Emulsions External preparations Suppositories and pessaries Powders and granules Sterile products Parenteral products Opthalmic products Inhaled products Parenteral nutrition and dialysis Radiopharmacy Specialized services Appliances Routes of administration and dosage forms

Read more less

Book SynopsisThis book explores the impact of Greek (as well as Indian and Persian) medical heritage on the evolution of Arab medicine and pharmacology, investigating it from the perspective of 'materia medica' a reliable indication of the contribution of this medical legacy.

Read more less

Book SynopsisThis new edition of Non-prescription Medicines reviews over-the-counter (OTC) medicines currently available in the UK, in alphabetically arranged chapters on the conditions that they are licensed to treat.

Read more less

Book SynopsisTable of ContentsUnit I: Basic Concepts and Principles in Pharmacology 1. Introduction to Respiratory Care Pharmacology 2. Principles of Drug Action 3. Administration of Aerosolized Agents 4. Calculating Drug Doses 5. The Central and Peripheral Nervous Systems Unit II: Drugs Used to Treat the Respiratory System 6. Adrenergic (Sympathomimetic) Bronchodilators 7. Anticholinergic (Parasympatholytic) Bronchodilators 8. Xanthines 9. Mucus-Controlling Drug Therapy 10. Surfactant Agents 11. Corticosteroids in Respiratory Care 12. Nonsteroidal Antiasthma Agents 13. Aerosolized Antiinfective Agents 14. Antimicrobial Agents 15. Cold and Cough Agents 16. Selected Agents of Pulmonary Value 17. Neonatal and Pediatric Aerosolized Drug Therapy Unit III: Critical Care, Cardiovascular, and Polysomnography Agents 18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents) 19. Diuretic Agents 20. Drugs Affecting the Central Nervous System 21. Vasopressors, Inotropes, and Antiarrhythmic Agents 22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics 23 Sleep and Sleep Pharmacology

Read more less

Book SynopsisThe best flashcards to test yourself on the top drugs & prepare for the NCLEX®! Increase your test scores in pharmacology class. Build your confidence to pass the NCLEX®. Expand your understanding of pharmacological agents. Decrease and prevent medication errors in practice. These flashcards put critical clinical information for nearly 400 of the top generic medications at your fingertips. Each card features a single generic drug or a medication group to help build associations between common medications and includes indications for use of the drug, action of the drug, route/dosage information, adverse reactions/side effects, pre-administration vital signs, laboratory data assessment, drug levels, patient teaching, and more. Count on them for accuracy because each card is based on content from Davis’s Drug Guide for Nurses®. AMAZING and MUST GET!“These cards are a MUST for any nursing student or even nurse! I use these for almost every single assignment from nursing process sheets to care plans. You need to get these immediately, and you’ll love them!! Seriously, I am so glad I stumbled upon these cards. Thank you to whoever invented these!”—Edgar G. GREAT for Nursing Students“I used these cards to pass my pharmacology final and my NCLEX in nursing school! I love these cards. They have all the info you need on the card, and even helpful tips.”—Cloie Updated & Revised! Completely reviewed and updated to ensure accuracy A color-coded, body-system organization reflects the information common to classes of medications. Each card features a single generic drug or a medication group to help build associations between common medications and includes indications for use of the drug, action of the drug, adverse reactions/side effects, pre-administration vital signs, laboratory data assessment, drug levels, patient teaching, and more. “Make the Connection” highlights information crucial to administering medications safely, understanding the clinical applicability of the information, and helps to develop critical-thinking skills. “Keep in Mind” provides key nursing considerations, including client teaching. Route/dosage information appears on the back of each card. Common abbreviations listed on each card, with a summary of the abbreviations on separate, introductory cards. A comprehensive, alphabetical Index makes it easy to locate drugs within the deck by trade, generic, or Canadian brand name. New! Card listing commonly used monoclonal antibodies, their brand and generic names, and indications for use New! Cards explaining the cytochrome P450 (CYP 450) enzyme system, how the enzymes effect the levels of other drugs with a list of strong and moderate inhibitors and inducers New! CYP3A4 inducer or inhibiter descriptions in the “Make the Connection” section on each card, when appropriate New! Cards for VMAT2 inhibiters in the central nervous system section Table of ContentsKey to Abbreviations Key to Icons Introduction Drug Cards covering... • Gastrointestinal System Drugs • Endocrine System Drugs • Urologic System Drugs • Immune System Drugs • Musculoskeletal System Drugs • Central Nervous System Drugs • Cardiovascular System Drugs • Respiratory System Drugs • Sensory System Drugs Index

Read more less

Book Synopsis

Read more less

Book SynopsisFor thousands of years fragrance has been used, across many varied cultures, for altering mental and emotional states, and as part of spiritual practice. This book explores the impact of fragrance on the psyche from biological, anthropological, perfumery and aromatherapy viewpoints. Beginning with an exploration of our olfactory system and a discussion of the language of odour, the author examines the ways in which fragrance can influence our perceptions and experiences. She introduces us to a broad range of fragrance types - woody, resinous, spicy, herbaceous, agrestic, floral and citrus, as well as the attars that form part of Unani Tibb medicine. Traditional and contemporary uses and the mood-enhancing properties of fragrance types are presented. The book then provides an overview of the theoretical and philosophical frameworks that have been used to analyse how and why we choose fragrance. Finally readers are given guidance on how to cultivate their olfactory palate, which reveals a new dimension in the use of fragrance to enhance wellbeing.This book offers a wealth of knowledge on plant aromatics and the powerful influence of fragrance on wellbeing. It will be of particular interest to aromatherapists, perfumers, psychotherapists, ethnobotanists and anthropologists.Trade ReviewThis book explores the impact of fragrance on the psyche from biological, anthropological, perfumery and aromatherapy viewpoints... Readers are given guidance on how to cultivate their olfactory plate, which reveals a new dimension in the use of fragrance to enhance wellbeing. This book offers a wealth of knowledge on plant aromatics and the powerful influence of fragrance on wellbeing. It will be of particular interest to aromatherapists, perfumers, psychotherapists, ethnobotanists and anthropologists. -- Embody MagazineThis book takes in a fantastic range of topics, including the biology of fragrance, the social life of scents, the healing powers of smell and incense rituals from around the world. Its central chapters profile the uses of an impressive list of aromatics (blending myth, folklore and science) and it concludes with some vital suggestions for cultivating our olfactory palate. Written by a true perfume lover, Fragrance and Wellbeing makes for heady reading. -- David Howes, Professor of Anthropology, Concordia University, Montreal and co-author of Aroma: The Cultural History of Smell (1994) and Ways of Sensing: Understanding the Senses in Society (2013)Jennifer Peace Rhind transports the reader on a fascinating journey while exploring the influence of scent on the development of civilization. This well-referenced book includes research within the last century regarding the use of fragrance throughout history. Fragrance and Wellbeing investigates our evolving relationship with the language of scent and its impact on the personal, cultural, spiritual and therapeutic domains with an acknowledgement to new observations for the possible effects of fragrance. A thoroughly interesting, informative and engaging read! -- Lora Cantele, Editor, International Journal of Professional Holistic AromatherapyA walk through an oriental bazaar, contemplation in a Hindu temple, and reading Rhind's Fragrance and Wellbeing are three experiences that provide a clear insight into what Westerners miss by pushing our sense of smell aside. By presenting ample cross-cultural, historical and psychological evidence, Rhind persuasively argues why we should take our nose seriously. -- Dr Jan Havlícek, Department of Anthropology, Charles University, Prague, Czech RepublicJennifer Peace Rhind's classic delivers an in depth explanation of the effect natural plant perfumes have on the human psyche. This work not only covers a scientific summary of plant chemistry, but also the historical use of plants in shamanic and mystical traditions throughout the world...In this great work, the author explores the various odour types and characteristics encountered in plant fragrances in great detail, and goes on to list and describe plant categories... Having read (or at least scanned) many books on the subject of "Aromatherapy", I have found Jennifer Peace Rhind's "Fragrance and Wellbeing" - to be the one which will remain on my bookshelf, to be referred to and delved into often. A great work which deserves much revisiting. -- The HerbalistJennifer Peace Rhind is a trained chartered biologist who then undertook further studies in complementary therapies, including aromatherapy... She explores the sense of smell and how it works with the psyche... the emotional response to odors.... The evolution of perfume is explored..introduces us to the language of fragrance... I found this book fascinating and full of really great information. -- Jo Ketterman MARH * Homeopathy in practice *[This book] addresses how fragrance strongly links to our soul and spirit, and how each aroma plays a different part in addressing the problems of the mind (...) [with] comprehensive descriptions of the wide variety of natural aromas to be found in the plant world (...) in my decade-plus long experience in the world of aromatherapy, I learned many new things from this book. -- Sharon Falsetto * NAHA Aromatherapy Journal, Winter 2017.4 *Table of ContentsPreface. Introduction. Part I. Scent: A Pan-Dimensional Perspective. 1. The Fallen Angel. 2. Smell and the psyche. 3. Per fumum. 4. Perfume: The transcendence of the sweet life. Part II. A Natural Palette of Aromatics. 5. Fragrance philosophies. 6. Woody, resinous, balsamic and coniferous scents. 7. Spices. 8. Herbaceous, green, camphoraceous, cineolic and agrestic scented botanicals. 9. Flowers. 10. Citrus, lemon-scented botanicals and fruity fragrances. 11. Attars and the role of fragrance in Unani Tibb medicine (Jeannie Fatimeh Graham). In conclusion. 12. Cultivating the olfactory palate. Glossary. Appendix A. Classification of fragrance. Appendix B. Ambergris. Appendix C. Fragrance and the four elements. Appendix D. Developing sensory appreciation of plant aromatics, essential oils, absolutes and fragrances. References. Bibliography for Chapter 11. Recommended reading.

Read more less

Book SynopsisThe Art, Science, and Technology of Pharmaceutical Compounding, 6th Edition has been completely revised and covers all aspects of pharmaceutical compounding. Featured are the regulations,technology, scientific foundation, and clinical consulting aspects of the dosage forms that can be compounded. It also contains example formulas for all dosage forms along with the ingredients, quantities, use of each ingredient, and instructions for preparation. In addition to formulation development including flavoring, sweetening, preservation and compliance and compatibility considerations, quality control and areas of potential errors are also presented.More than ever, there is a need for a practical compounding reference that integrates the science and practice of compounding while emphasizing the need for caution, innovation, and patient counseling.KEY FEATURES: Covers all aspects of nonsterile and sterile as well as nonhazardous and hazardous compounding. Blends the scientific and technologic aspects of compounding to support an understanding of the importance of each compounded dosage form. Presents different technologies for compounding various dosage forms, as well as example. Formulations for all dosage forms presented in the book. Features an entirely new chapter emphasizing the pharmacist’s role in addressing incompatibilities and their potential clinical effects.

Read more less

Book SynopsisThe fifth edition of this popular textbook continues to provide a solid foundation of pharmacological knowledge for all those working in anaesthesia and intensive care. The content has been thoroughly revised to include expanded chapters with clearer figures, ensuring readers are kept abreast of the ever-changing landscape of clinical pharmacology. Conveniently divided into four sections covering the basic principles of pharmacology, core drugs in anaesthetic practice, cardiovascular drugs, and other important drugs and complemented by new diagrams, tables and chemical formulae to facilitate learning. All four chapters on core drugs in anaesthetic practice have been updated along with others exploring applied pharmacokinetic models, antimicrobials, and drugs used in diabetes. An ideal aid to study and practice for junior and trainee anaesthetists and intensive care specialists preparing for exams. Also an invaluable resource for theatre practitioners, ICU nurses and physicians working in areas that demand a solid knowledge of pharmacology.Trade Review'This outstanding book differentiates itself from others through its effective use of figures and diagrams that enhance learning. It is comprehensive and provides sufficient detail for the use of these medications. The information is not so overwhelming as to render it forgotten after reading. The inclusion of new anticoagulants and their reversal and the update on antibiotics make this new edition necessary.' Robert R. Gaiser, Doody's Notes'… an invaluable resource for anyone, both doctor or nurse/ODP working in anaesthesia and intensive care. Its well-written explanations on the topics offer easy to understand insight which will only benefit the reader and lead to a greater depth of knowledge.' Daniel Morgan, The Journal of Perioperative Practice'A pleasant surprise for the reader will be how easily these subsections flow as the authors keep the more detailed and in-depth information accessible and interesting by associating the concepts to relevant drugs … This book is useful for trainees preparing for examinations and for experienced practitioners as a shelf reference; it is well organised so that specific topics or drugs can be individually reviewed.' Daniel Pulsipher, British Journal of AnaesthesiaTable of ContentsPreface: Foreword by Anthony Absalom; Section I. Basic Principles: 1. Drug passage across the cell membrane; 2. Absorption, distribution, metabolism and excretion; 3. Drug action; 4. Drug interaction; 5. Isomerism; 6. Pharmacokinetic modelling; 7. Applied pharmacokinetic models; 8. medicinal chemistry; Section II. Core Drugs in Anaesthetic Practice: 9. General anaesthetic agents; 10. Analgesics; 11. Local anaesthetics; 12. Muscle relaxants and reversal agents; Section III. Cardiovascular Drugs: 13. Sympathomimetics; 14. Adrenoceptor antagonists; 15. Anti-arrhythmics; 16. Vasodilators; 17. Antihypertensives; Section IV. Other Important Drugs: 18. Central nervous system; 19. Antiemetics and related drugs; 20. Drugs acting on the gut; 21. Intravenous fluids, minerals and nutrition; 22. Diuretics; 23. Antimicrobials; 24. Drugs affecting coagulation; 25. Drugs used in diabetes; 26. Corticosteroids and other hormone preparations; Index.

Read more less

Book SynopsisTable of ContentsSection 1 Introduction and Background 1. Development of the pharmaceutical industry 2. Nature of disease and purpose of therapy 3. Therapeutic modalities Section 2 Drug Discovery 4. Drug target identification 5. Selecting the modality and planning the project 6. High throughput screening 7. Medicinal Chemistry 8. Biopharmaceuticals and related molecules 9. Emerging modalities: nucleotide based therapy, cell based therapy, gene therapy / Novel and Advanced Process 10. Metabolism and Pharmacokinetical strategies. 11. Role of pharmacology to include pharmacology of newer modalities 12. In vitro in vivo translation 13. Vaccines Section 3 Drug Development 14. Drug development introduction 15. Drug safety 16. Pharmaceutical development 17. Clinical development 18. Clinical imaging 19. Intellectual property 20. Regulatory affairs 21. Marketing and Patient access to medicines Section 4 Facts and Figures 22. Facts and Figures; and the Future

Read more less

Book SynopsisVaccine Production and Manufacturing is a valuable reference on how to produce a vaccine, from beginning to end. It addresses all classes of vaccines from a processing, production, and regulatory viewpoint. It covers everything from fermentation, purification, and formulation to regulatory filing and facility design.Table of ContentsAcknowledgments vii Preface ix Contributors xi 1 History of Vaccine Process Development 1Narahari S. Pujar, Sangeetha L. Sagar, and Ann L. Lee 2 The Production of Plasmid DNA Vaccine in Escherichia coli: A Novel Bacterial-Based Vaccine Production Platform 25Michel Chartrain 3 Fungal Expression Systems for Vaccine Production 51Karl Melber, Volker Jenzelewski, Roland Weyhenmeyer, and Zbigniew Janowicz 4 Novel Expression Systems for Vaccine Production 81Shailaja Rabindran and Vidadi Yusibov 5 Viral Vaccines Purification 97Bernd Kalbfuss-Zimmermann and Udo Reichl 6 Protein Subunit Vaccine Purification 181Yan-ping Yang and Tony D’Amore 7 Conjugate Vaccine Production Technology 217Sudha Chennasamudram and Willie F. Vann 8 Stabilization and Formulation of Vaccines 237Timothy S. Priddy and C. Russell Middaugh 9 Lyophilization in Vaccine Processes 263Alexis Wasserman, Ranjit Sarpal, and Bret R. Phillips 10 Strategies for Heat-Stable Vaccines 287Satoshi Ohtake, David Lechuga-Ballesteros, Vu Truong-Le, and Eric J. Patzer 11 Production and Characterization of Aluminum-Containing Adjuvants 319Stanley L. Hem and Cliff T. Johnston 12 The Biologics License Application (BLA) in Common Technical Document (CTD) Format 347R.S. Robin Robinett 13 The Original New Drug Application (Investigational New Drug) 373R.S. Robin Robinett 14 Facility Design for Vaccine Manufacturing—Regulatory, Business, and Technical Considerations and A Risk-Based Design Approach 393Anand Ekambaram and Abraham Shamir 15 Vaccine Production Economics 413Andrew Sinclair and Peter Latham Index 437

Read more less

Book SynopsisA comprehensive examination of Low Dose Naltrexone – a little-known drug with big potential New drug [LDN] raises hopes of reversing memory loss in old age the Guardian A drug that is simultaneously affordable, devoid of severe side effects, and applicable to a wide range of diseases is not often found in the modern pharmaceutical landscape. But as medical professionals and researchers alike continue to discover, Low Dose Naltrexone (LDN) boasts this remarkable combination. Expanding on the information presented in The LDN Book, Volume 1 – which showcased LDN’s efficacy in treating conditions such as lupus, thyroiditis, autism spectrum disorder, and chronic fatigue – Volume 2 highlights the latest clinical trials, case studies and research on LDN. More than a dozen medical professionals explain how they are using LDN to help patients suffering from: Chronic pain Parkinson’s disease Dermatologic conditions Traumatic brain injury Lyme disease and more. Volume 1 and Volume 2 have been edited by Linda Elsegood, founder of the UK-based LDN Research Trust. Through the Trust and her work on the LDN books, Linda has connected thousands of patients, doctors and pharmacists around the world with information, articles and patient stories about LDN. The LDN Book, Volume 2 is a fantastic resource for practitioners, pharmacists and patients and a renewed call for further research on the healing potential of this beneficial drug.Trade Review“Since the first volume of The LDN Book was released, I have had the distinct privilege of learning from and collaborating with the best clinicians and researchers in the field of integrative medicine. Through these collaborations, we continue to build upon the already vast applications of this low-dose but high-power medication. I am thrilled to see so many trusted colleagues, who have also become friends, contribute to this important body of work. Thank you, again, Linda Elsegood, for bringing together a tribe of like-minded people who continue to find solutions to challenging medical issues with this simple and inexpensive intervention.”—Dr. Nasha Winters, ND, FABNO, author of The Metabolic Approach to Cancer“As a pharmacist, I often wish for a ‘miracle’ drug that would be safe, effective, and inexpensive and could help the masses take back their health. While no drug is right for everyone, I have seen LDN transform the lives of countless people with autoimmunity. For some, LDN has truly been a miracle drug. I highly recommend both volumes of The LDN Book as valuable resources for patients and clinicians alike to explore the best practices for using LDN.”—Dr. Izabella Wentz, Pharm.D., FASCP, New York Times bestselling author of Hashimoto’s Protocol“A fantastic resource. All the latest research on low dose naltrexone and its various uses in clinical practice is compiled in this easy-to-use volume—The LDN Book, Volume 2. I will definitely be keeping this book in my office for reference.”—Jill C. Carnahan, MD, ABIHM, ABoIM, IFMCP“Even if you think you know about the benefits of LDN for certain conditions through practical experience or otherwise, this book will expand your understanding and amazement. It is a remarkable finding that a drug designed for a specific condition can be applied to so many other systems at lower and lower doses. Interestingly, this has shown us that many other drugs may also have unexpected benefits at lower-than-intended doses. There are many layers of complexity that remain to be uncovered!”—Dr. Angus Dalgleish, professor of oncology, St. George’s, University of London; principal, Institute for Cancer Vaccines and Immunotherapy (ICVI)“Over the years, a wealth of clinical trials and studies on LDN have given us better information about how and why LDN actually works. Through this research, we have uncovered many new uses of LDN in medical treatment. Reviewing The LDN Book, Volume 2 and seeing how other experts prescribe LDN in their clinics has been a great treat for me. My clinic, Clinic 158, has been prescribing LDN for 12 years. We have thousands of very happy patients who have found success with the medication for a myriad of ailments, and we are still learning new information.”—Dr. Andrew McCall, director, Clinic 158“Since inflammation is a major contributor to almost all chronic disorders, LDN therapy bridges nearly every medical specialty. In The LDN Book, Volume 2, the authors provide an excellent overview of LDN’s mechanism of action, review the vast evidence base supporting clinical applications, and, most importantly, report actual cases in which LDN was instrumental in the successful treatment of patients. This book is a must-have for every clinician, and LDN should be considered in the treatment of the many disorders outlined therein.”—Sahar Swidan, Pharm.D., R.Ph., ABAAHP, FAARFM, FACA, president and CEO, Pharmacy Solutions

Read more less

Book SynopsisPublisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product.SMALL ENOUGH TO FIT IN YOUR POCKET, DETAILED ENOUGH TO PROVIDE EVERYTHING YOU NEED TO KNOW Essential data on more than 1,000 of the most commonly used prescribed medications and more than 75 drugs most often used in the pre-hospital setting Drug-specific EMS pearls, including signs and symptoms of overdose and specific overdose management Sections on popular medicinal herbs and common street drugs Quick-reference tables encapsulate essential information Street Drug section updated to include "bath salts" and salvia Table of ContentsMedication KeyAbbreviationsEMS Field Medications: Prehospital Drug Classification Commonly Prescribed Medications: ClassificationCommonly Prescribed Medications: Generic and Selected Brand DataCommonly Used Medicinal HerbsCommon Street drugsTablesIndex

Read more less

Book SynopsisTable of Contents1. Overview of Biotherapeutics and Vaccine Industry 2. Industrial Process Design Concepts 3. Single-Use Concepts in Manufacturing 4. Equipment and Automation 5. Facility Design 6. Process Development Routines 7. Production Sources and their Selection 8. Upstream Processing 9. Downstream Processing 1: Recovery Process 10. Downstream Processing 2: Purification Process 11. Downstream Related Methods 12. Analytics 13. Regulatory Aspects 14. Manufacturing Operations 15. Economics

Read more less

Book Synopsis

Read more less

Book SynopsisTable of ContentsSection I. Applications of nutraceuticals in common diseases and disorders 1. Nutraceuticals in central nervous system diseases: potential mechanisms of neuroprotection 2. Prevention of neurodegenerative disorders by nutraceuticals 3. Cognitive effects of nutraceuticals 4. Nutraceuticals in anxiety and stress 5. Countering cardiovascular diseases with nutraceuticals 6. Nutraceuticals for diabetes and glucose balance 7. Role of nutraceuticals in respiratory and allied diseases 8. Nutraceuticals in hepatic diseases 9. Nutraceuticals in renal diseases 10. Nutraceuticals in gastrointestinal disorders 11. Nutraceuticals in reproductive and developmental disorders 12. Nutraceuticals in ophthalmic diseases 13. Nutraceuticals in dermal diseases 14. Nutraceuticals in arthritis 15. Nutraceuticals in sports activities and fatigue 16. Role of nutraceuticals as adaptogens 17. Nutraceuticals for weight loss 18. Nutraceuticals in cancer prevention 19. Application of “nano” nutraceuticals in medicine Section II. Models and mechanisms in evaluation of nutraceuticals 20. The biology of nutrients: genetic and molecular principles 21. Genomic and proteomic mechanisms and models in toxicity and safety evaluation of nutraceuticals 22. Transcriptomic profiling for safety and toxicity evaluation of nutraceuticals 23. Target identification and polypharmacology of nutraceuticals 24. Systems pharmacology investigation of mechanism of action of nutraceuticals 25. Noninvasive in vivo optical imaging models for safety and toxicity testing 26. Flow cytometry and light-scattering techniques in evaluation of nutraceuticals 27. Zebrafish as a model system to evaluate the safety and toxicity of nutraceuticals 28. Caenorhabditis elegans: an elegant model organism for evaluating the neuroprotective and neurotherapeutic potential of nutraceuticals 29. Alternative in vitro models for safety and toxicity evaluation of nutraceuticals 30. Mitochondria as a target for safety and toxicity evaluation of nutraceuticals 31. Oxidative stress and excitotoxicity: antioxidants from nutraceuticals Section III. Common nutraceuticals 32. Caffeine: an evaluation of the safety database 33. Biological activities and potential nanotechnological delivery of resveratrol 34. Melatonin: a safe nutraceutical and clinical agent 35. Standardized turmeric and curcumin 36. Curcuminoid-metal complexes for oxidative stress 37. Fenugreek: multiple health benefits 38. Cannabis sativa: an overview 39. Cannabidiol safety 40. St John’s wort (Hypericum perforatum L) 41. Green tea 42. Green coffee beans 43. Quercetin 44. German chamomile 45. Isoflavones: toxicological aspects and efficacy 46. Propolis 47. Bee products as nutraceuticals to nutraceuticals for bees 48. Ginkgo biloba 49. Chinese ginseng 50. Ashwagandha: multiple health benefits 51. Astaxanthin: health benefits and toxicity 52. Thymoquinone 53. Glucosinolates 54. Organosulfur compounds as nutraceuticals 55. Arginine and citrulline as nutraceuticals: efficacy and safety in diseases 56. Neem Extract 57. Spirulina 58. Garcinia cambogia 59. Vitamin E TPGS and its applications in nutraceuticals 60. Role of transferrin: an iron-binding protein in health and diseases 61. Glutamine supplementation: hope, hype, or stay tuned? 62. What to do with placenta after birth: is it a waste? 63. Chitin, chitosan, and their derivatives Section IV. Prebiotics and probiotics 64. Prebiotics: safety and toxicity considerations 65. Probiotics: safety and toxicity considerations 66. Synbiotics: safety and toxicity considerations Section V. Nutraceuticals in veterinary medicine 67. Nutraceuticals in animal health and diseases Section VI. Toxicity and toxic interactions 68. Toxic contamination of nutraceuticals and food ingredients 69. Nutraceuticals and adverse outcome pathways 70. Interactions between nutraceuticals/nutrients and nutrients and therapeutic drugs 71. Genotoxicity evaluation of nutraceuticals Section VII. Regulatory aspects 72. The regulatory framework for nutraceuticals: North America 73. Evaluation and regulation of food supplements: European perspective 74. Regulatory guidelines for nutraceuticals in India: an overview 75. Regulatory aspects of nutraceuticals: Chinese perspective 76. Uses and regulation of nutraceuticals: Australia and New Zealand 77. Regulatory aspects of nutraceuticals: Japanese perspective 78. Nutraceuticals: the Turkish perspective

Read more less

Book SynopsisThe completely revised and expanded Student Workbook offers readers more practice and review opportunities that are tied to the learning goals in Focus on Pharmacology: Essentials for Health Professionals , Third Edition. The Workbook contains many different types of review questions, including multiple-choice, fill-in-the-blank, true/false, and critical-thinking.

Read more less

Book Synopsis

Read more less